Aktienanalyse zu Bonk Inc (BNKK)BNKKBonk Inc

Bonk, Inc., formerly Safety Shot, Inc., is a wellness and dietary supplement company. The Company has developed Sure Shot, which is a patented wellness product that lowers blood alcohol content. In approximately 30 minutes, this product helps the body break down alcohol. Its bottles and stick packs are sold direct-to-consumer (D2C) and via retail partners. D2C orders through the Sure Shot Website are fulfilled via a 3PL with additional sales through online outlets. Sure Shot is available for purchase online at www.sureshot.com, www.walmart.com and Amazon. It has also introduced business-to-business sales of Sure Shot to distributors, retailers, restaurants and bars. It also makes energy beverages with yerba mate and other plant-based ingredients. Its energy beverages are zero calorie, zero sugar, non-genetically modified organism, vegan, kosher, keto-friendly, paleo-approved, gluten-free and diabetic-friendly. The Company is focused on building a digital asset treasury. It operates in the Consumer Non-Cyclicals sector.

Bonk Inc (BNKK) is a good buy right now due to its current price of 1.21, which is significantly lower than its historical SMA of 200 days at 2.225, suggesting potential for recovery. Additionally, the gross margin has improved to 82.85% in Q1 2026, indicating strong profitability potential moving forward. However, the main risk is the RSI at 22.036, indicating the stock is oversold and may face further downward pressure in the short term.